215 related articles for article (PubMed ID: 32053843)
21. Cushing's disease: towards precision medicine.
Kaiser UB
Cell Res; 2015 Jun; 25(6):649-50. PubMed ID: 25930709
[TBL] [Abstract][Full Text] [Related]
22. A long-term prognosis study of human USP8-mutated ACTH-secreting pituitary neuroendocrine tumours.
Miao H; Wang L; Gong F; Duan L; Wang L; Yao Y; Feng M; Deng K; Wang R; Xiao Y; Ling Q; Zhu H; Lu L
Clin Endocrinol (Oxf); 2024 Jul; 101(1):32-41. PubMed ID: 38691659
[TBL] [Abstract][Full Text] [Related]
23. Genetics of Cushing's disease: from the lab to clinical practice.
Theodoropoulou M; Reincke M
Pituitary; 2022 Oct; 25(5):689-692. PubMed ID: 35852754
[TBL] [Abstract][Full Text] [Related]
24. Genetics of Cushing's disease.
Albani A; Theodoropoulou M; Reincke M
Clin Endocrinol (Oxf); 2018 Jan; 88(1):3-12. PubMed ID: 28850717
[TBL] [Abstract][Full Text] [Related]
25. Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas.
Sbiera S; Tryfonidou MA; Weigand I; Grinwis GC; Broeckx B; Herterich S; Allolio B; Deutschbein T; Fassnacht M; Meij BP
PLoS One; 2016; 11(12):e0169009. PubMed ID: 28005997
[TBL] [Abstract][Full Text] [Related]
26. Cushing's disease due to somatic USP8 mutations: a systematic review and meta-analysis.
Wanichi IQ; de Paula Mariani BM; Frassetto FP; Siqueira SAC; de Castro Musolino NR; Cunha-Neto MBC; Ochman G; Cescato VAS; Machado MC; Trarbach EB; Bronstein MD; Fragoso MCBV
Pituitary; 2019 Aug; 22(4):435-442. PubMed ID: 31273566
[TBL] [Abstract][Full Text] [Related]
27. USP8, USP48, and BRAF mutations differ in their genotype-phenotype correlation in Asian Indian patients with Cushing's disease.
Abraham AP; Pai R; Beno DL; Chacko G; Asha HS; Rajaratnam S; Kapoor N; Thomas N; Chacko AG
Endocrine; 2022 Feb; 75(2):549-559. PubMed ID: 34664215
[TBL] [Abstract][Full Text] [Related]
28. Responsiveness to DDAVP in Cushing's disease is associated with USP8 mutations through enhancing AVPR1B promoter activity.
Shichi H; Fukuoka H; Kanzawa M; Yamamoto M; Yamamoto N; Suzuki M; Urai S; Matsumoto R; Kanie K; Fujita Y; Bando H; Iguchi G; Inoshita N; Yamada S; Takahashi Y; Ogawa W
Pituitary; 2022 Jun; 25(3):496-507. PubMed ID: 35451730
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation.
Kageyama K; Asari Y; Sugimoto Y; Niioka K; Daimon M
Endocr J; 2020 Feb; 67(2):177-184. PubMed ID: 31666445
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin-specific protease 8 (USP8/UBPy): a prototypic multidomain deubiquitinating enzyme with pleiotropic functions.
Dufner A; Knobeloch KP
Biochem Soc Trans; 2019 Dec; 47(6):1867-1879. PubMed ID: 31845722
[TBL] [Abstract][Full Text] [Related]
31. Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report.
Bao XD; Lu L; Zhu HJ; Yao Y; Feng M; Wang RZ; Zhai X; Fu Y; Gong FY; Lu ZL
BMC Endocr Disord; 2022 Jun; 22(1):152. PubMed ID: 35668434
[TBL] [Abstract][Full Text] [Related]
32. Biophysical and structural insight into the USP8/14-3-3 interaction.
Centorrino F; Ballone A; Wolter M; Ottmann C
FEBS Lett; 2018 Apr; 592(7):1211-1220. PubMed ID: 29473952
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis of ubiquitin-specific protease 8 autoinhibition by the WW-like domain.
Kakihara K; Asamizu K; Moritsugu K; Kubo M; Kitaguchi T; Endo A; Kidera A; Ikeguchi M; Kato A; Komada M; Fukushima T
Commun Biol; 2021 Nov; 4(1):1272. PubMed ID: 34750505
[TBL] [Abstract][Full Text] [Related]
34. Improved pasireotide response in USP8 mutant corticotroph tumours in vitro.
Albani A; Perez-Rivas LG; Tang S; Simon J; Lucia KE; Colón-Bolea P; Schopohl J; Roeber S; Buchfelder M; Rotermund R; Flitsch J; Thorsteinsdottir J; Herms J; Stalla G; Reincke M; Theodoropoulou M
Endocr Relat Cancer; 2022 Aug; 29(8):503-511. PubMed ID: 35686696
[TBL] [Abstract][Full Text] [Related]
35. Case Report: Consecutive Adrenal Cushing's Syndrome and Cushing's Disease in a Patient With Somatic
Detomas M; Altieri B; Schlötelburg W; Appenzeller S; Schlaffer S; Coras R; Schirbel A; Wild V; Kroiss M; Sbiera S; Fassnacht M; Deutschbein T
Front Endocrinol (Lausanne); 2021; 12():731579. PubMed ID: 34489873
[TBL] [Abstract][Full Text] [Related]
36. USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs.
Treppiedi D; Di Muro G; Marra G; Barbieri AM; Mangili F; Catalano R; Serban A; Ferrante E; Locatelli M; Lania AG; Arosio M; Spada A; Peverelli E; Mantovani G
Endocr Relat Cancer; 2021 Jun; 28(8):573-582. PubMed ID: 34086599
[TBL] [Abstract][Full Text] [Related]
37. Genetics: New mutations in Cushing disease identified.
Greenhill C
Nat Rev Endocrinol; 2015 Mar; 11(3):131. PubMed ID: 25534197
[No Abstract] [Full Text] [Related]
38. Germline USP8 Mutation Associated With Pediatric Cushing Disease and Other Clinical Features: A New Syndrome.
Cohen M; Persky R; Stegemann R; Hernández-Ramírez LC; Zeltser D; Lodish MB; Chen A; Keil MF; Tatsi C; Faucz FR; Buchner DA; Stratakis CA; Tiosano D
J Clin Endocrinol Metab; 2019 Oct; 104(10):4676-4682. PubMed ID: 31162547
[TBL] [Abstract][Full Text] [Related]
39. Driver mutations in USP8 wild-type Cushing's disease.
Sbiera S; Perez-Rivas LG; Taranets L; Weigand I; Flitsch J; Graf E; Monoranu CM; Saeger W; Hagel C; Honegger J; Assie G; Hermus AR; Stalla GK; Herterich S; Ronchi CL; Deutschbein T; Reincke M; Strom TM; Popov N; Theodoropoulou M; Fassnacht M
Neuro Oncol; 2019 Oct; 21(10):1273-1283. PubMed ID: 31222332
[TBL] [Abstract][Full Text] [Related]
40. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.
Ronchi CL; Peverelli E; Herterich S; Weigand I; Mantovani G; Schwarzmayr T; Sbiera S; Allolio B; Honegger J; Appenzeller S; Lania AG; Reincke M; Calebiro D; Spada A; Buchfelder M; Flitsch J; Strom TM; Fassnacht M
Eur J Endocrinol; 2016 Mar; 174(3):363-72. PubMed ID: 26701869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
